Stay updated with breaking news from Study Organization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This phase 1 study evaluated the safety and tolerability of 4 different doses of a short interfering RNA designed to reduce hepatic production of apolipoprotein
The study aimed to explore and describe the experiences of participation in MIND-ADMINI among persons with prodromal Alzheimer’s disease.
This randomized clinical trial assesses whether aspirin, prophylactic-dose apixaban, or therapeutic-dose apixaban, compared with placebo, can safely reduce majo
Orientierungsabend der Bauhaus-Universität läuft am 19. August wiederum in digitaler Form.